Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7257 p42
12 July 2003

This article
Reprint
Photocopy


News summary

Related websites
Xenova (www.xenova.co.uk)


Cocaine dependence vaccine

Xenova has reported results from phase II studies showing its vaccine, TA-CD, for cocaine dependence is safe and well tolerated with a dose-related immune response. Of 16 patients who used cocaine after vaccination, 14 reported a reduction of the usual euphoric effect associated with cocaine use.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal